LianBio American Depositary Shares
LIAN
LIAN was delisted on the 18th of March, 2024.
39 hedge funds and large institutions have $183M invested in LianBio American Depositary Shares in 2023 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
16% more capital invested
Capital invested by funds: $157M → $183M (+$25.8M)
8% more funds holding
Funds holding: 36 → 39 (+3)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.73M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$397K |
| 3 |
AAA
Affinity Asset Advisors
New York
|
+$346K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$327K |
| 5 |
SG Americas Securities
New York
|
+$135K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.01M |
| 2 |
Millennium Management
New York
|
-$365K |
| 3 |
CIC
Cornercap Investment Counsel
Atlanta,
Georgia
|
-$145K |
| 4 |
Barclays
London,
United Kingdom
|
-$91.9K |
| 5 |
BlackRock
New York
|
-$61.5K |
LIAN Hedge Fund Activity: Q2 2023 in Review
39 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in LianBio American Depositary Shares (LIAN) for Q2 2023, worth a combined $183M — up 16% from $157M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new LIAN positions and 4 closed out — a net gain of 3 holders — while 9 added to existing stakes and 9 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $1.73M. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.01M sold.
- 39 institutional investors held LianBio American Depositary Shares (LIAN) as of Q2 2023, up from 36 in Q1 2023.
- Funds reported $183M of LianBio American Depositary Shares stock for Q2 2023, up 16% quarter-over-quarter.
- 7 funds opened new LianBio American Depositary Shares positions in Q2 2023 and 4 closed out, a net change of +3 holders.
- The largest LianBio American Depositary Shares buyer in Q2 2023 was Tang Capital Management, an estimated $1.73M added.
- The largest LianBio American Depositary Shares seller in Q2 2023 was Wellington Management Group, an estimated $2.01M sold.
Based on aggregated 13F filings for Q2 2023.